New drug trial targets debilitating itch in liver disease patients
Symptom relief
Not yet recruiting
This study is testing whether an investigational drug called TH104 can safely reduce severe itching in people with primary biliary cholangitis (PBC), a chronic liver disease. Forty participants with moderate to severe itching will receive either TH104 or a placebo for six weeks, …
Phase: PHASE2 • Sponsor: Tharimmune Inc • Aim: Symptom relief
Last updated Apr 01, 2026 14:41 UTC